Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (3)
- Biological Systems (2)
- Biology and Environment (101)
- Biology and Soft Matter (1)
- Clean Energy (78)
- Climate and Environmental Systems (5)
- Computational Engineering (1)
- Computer Science (3)
- Electricity and Smart Grid (2)
- Fusion and Fission (19)
- Fusion Energy (13)
- Materials (43)
- Materials for Computing (10)
- Mathematics (1)
- National Security (15)
- Neutron Science (60)
- Nuclear Science and Technology (17)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (3)
- Sensors and Controls (1)
- Supercomputing (50)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.